Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
Mary Beth F SonNancy MurrayKevin FriedmanCameron C YoungMargaret M NewhamsLeora R FeldsteinLaura L LoftisKeiko M TarquinioAalok R SinghSabrina M HeidemannVijaya L SomaBecky J RiggsJulie C FitzgeraldMichele KongSule DoymazJohn S GiulianoMichael A KeenaghanJanet R HumeCharlotte V HobbsJennifer E SchusterKatharine N ClouserMark W HallLincoln S SmithSteven M HorwitzStephanie P SchwartzKatherine IrbyTamara T BradfordAline B MadduxChristopher J BabbittCourtney M RowanGwenn E McLaughlinPhoebe H YagerMia MaamariElizabeth H MackChristopher L CarrollVicki L MontgomeryNatasha B HalasaNatalie Z CvijanovichBria M CoatesCharles E RoseJane W NewburgerManish M PatelAdrienne G Randolphnull nullPublished in: The New England journal of medicine (2021)
Among children and adolescents with MIS-C, initial treatment with IVIG plus glucocorticoids was associated with a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. (Funded by the Centers for Disease Control and Prevention.).